Corpus Intelligence IC Memo — DIGNITY HEALTH REHABILITATION HOSPIT 2026-04-26 06:40 UTC
IC Memo — DIGNITY HEALTH REHABILITATION HOSPIT
Investment Committee Memorandum | NV | 60 beds | Grade D | EBITDA uplift $3.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

DIGNITY HEALTH REHABILITATION HOSPIT

CCN 293035 | CLARK, NV | 60 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

DIGNITY HEALTH REHABILITATION HOSPIT is a 60-bed suburban community hospital in CLARK, NV with $41.4M in net patient revenue and a 12.1% operating margin. The hospital serves a payer mix of 71.5% Medicare, 5.8% Medicaid, and 22.7% commercial.

Thesis: Turnaround. Our ML models identify $3.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 12.1% to 19.5% (+736bps).

Net Revenue HCRIS$41.4M
Current EBITDA COMPUTED$5.0M
Operating Margin COMPUTED12.1%
Occupancy HCRIS88.7%
Revenue / Bed COMPUTED$690K
Net-to-Gross HCRIS34.4%
Distress Probability ML42.6%

2. Market Context & Competitive Position

58
NV Hospitals
0.4%
State Median Margin
16
Comparable Hospitals

NV has 58 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of 12.1% places it above the state median. Among 16 size-comparable peers (30-120 beds), the median margin is 4.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (30-120), prioritizing same-state peers. 16 hospitals in the comp set.

HospitalStateBedsRevenueMargin
DIGNITY HEALTH REHABILITATION (Target)NV60$41.4M12.1%
NORTHERN NEVADA MEDICAL CENTERNV88$150.8M10.5%
RENOWN SOUTH MEADOWS MED CTRNV78$91.0M4.0%
NORTHEASTERN NEVADA REGIONAL HNV59$84.2M15.5%
DIGINTY HEALTH ST ROSE DOMINICNV32$61.5M12.2%
KINDRED HOSPITAL LAS VEGASNV118$52.3M-10.6%
HORIZON SPEC HOSPITAL-LAS VEGANV100$44.1M-2.2%
PAM SPECIALTY HOSPITAL OF LAS NV70$37.9M10.1%
PAM REHAB HOSP OF CENTENNIAL HNV44$35.7M29.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$869K+210bp18mo
Cost to Collect4.5%2.5%$828K+200bp12mo
Denial Rate Reduction12.0%6.5%$820K+198bp12mo
A/R Days Reduction5200.0%3800.0%$504K+122bp9mo
Clean Claim Rate88.0%96.0%$26K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$869K
Cost to Collect
$828K
Denial Rate Reduction
$820K
A/R Days Reduction
$504K
Clean Claim Rate
$26K
Total EBITDA Uplift$3.0M
Current EBITDA$5.0M
+ RCM Uplift+$3.0M
Pro Forma EBITDA$8.1M
Current Margin12.1%
Pro Forma Margin19.5%
WC Released (1x)$1.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$7.7M$63.6M8.24x52.5%
Base (11x exit)10.0x11.0x$7.7M$72.4M9.39x56.5%
Bull Case9.0x11.0x$6.9M$85.0M12.24x65.0%
Bull (12x exit)9.0x12.0x$6.9M$94.8M13.65x68.7%
Bear Case11.0x10.0x$8.5M$45.8M5.40x40.1%
Bear (11x exit)11.0x11.0x$8.5M$53.1M6.26x44.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 71.5% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 16 hospitals with 30-120 beds
  • Same-state prioritization (n=17)
  • Comp margins: P25=-1.9% / P50=4.5% / P75=12.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.